Luteinizing hormone Terminated Phase 3 Trials for Reproductive Techniques, Assisted Treatment

IndicationsStatusPurposePhase
TerminatedTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT01071200Study to Evaluate if the Addition of r-hLH (LuverisĀ®) to FSH From Day 8 of Ovarian Stimulation is Able to Decrease Total FSH Dose and to Improve Cycle Outcome in Infertile Women Undergoing ART, Who Required High FSH Dose in a Previous Cycle